Clinical trials
Drug clinical trial news involving companies such as Intellia, ActiGraph, Light Sciences Oncology, Nektar Therapeutics, Vir and Bellerophon Therapeutics, and drugs such as lecanemab and Wegovy. There’s also coverage of how to increase diversity in pharmaceutical clinical trials, animal welfare in clinical research, and an in-depth story on why a failed clinical trial doesn’t always spell doom for a new drug.
Latest
STAT Plus: Icon acquires HumanFirst to boost support for digital tools in clinical trials
STAT Plus: Ocular Therapeutix moves in the right direction, and Alnylam tries to calm some nerves
STAT Plus: FDA gives a mixed response to a petition seeking greater clinical trial transparency
STAT Plus: Biotech launches with $135 million for Vertex-competing pain medicine
STAT Plus: Lasers, cardiology, clinical trials: 2023’s top private equity targets
STAT Plus: Survey: Confusion over key requirements means clinical trials aren’t registered and results aren’t reported
STAT Plus: Bayer’s promising menopause drug trial results highlight growing interest in long-neglected condition
All Coverage
advertisement
